| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_709b4a26ef028713f9b302509eb824d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91273007cfbe14bc524166a3aff3c2d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aeddc1170c55bb171ea2d9c9636042f |
| publicationDate |
1997-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9720072-A1 |
| titleOfInvention |
Compositions and methods of developing oligonucleotides and oligonucleotide analogs having antiviral activity |
| abstract |
Methods of identifying and preparing nucleic acid compounds that bind to RSV and potentially have anti-viral activity are disclosed, as well as nucleic acid compositions having anti-viral activity. The methods comprise iterative binding, separating and amplifying of nucleic acids or nucleic acid analogs (SELEX) using an intact virus as the receptor molecule. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2390257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4219516-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2392580-A1 |
| priorityDate |
1995-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |